Merck completes tender offer for $11B Acceleron Pharma acquisition
Over the current book year the company from Kenilworth could achieve a revenue around 48.95 billion USD (consensus estimates). This is slightly more than 2021's revenue of 47.99 billion USD.
Historical revenues and results Merck KGaA & Co plus estimates 2021
The analysts expect for 2021 a net profit of 14.64 billion USD. For this year the consensus of Merck KGaA & Co's result per share is a profit of 5.82 USD. The price-earnings-ratio equals 13.87.
Huge dividend Merck KGaA & Co
Analysts expect a dividend of 2.57 USD per share. The dividend yield is then 3.18 percent. The average dividend yield of the pharmaceutical companies is a poor 1.37 percent.Merck KGaA & Co's market capitalization is based on the number of outstanding shares around 204.9 billion USD. 9
On Friday, the stock closed at 80.7 USD.Historical stock prices Merck KGaA & Co from 2007 till 2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
